69 Best Biomedical Engineering Startups to Watch in 2024

RNA-guided regulatory genome targeting therapeutics developer for chronic diseases.

Total Raised: $1018.00M

Last Funding: $1000.00M (Series D)

RNA-guided regulatory genome targeting therapeutics developer for chronic diseases.

Total Raised: $1000.00M

Last Funding: $1000.00M (Series D)

Comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes

Total Raised: $313.00M

Last Funding: $18.00M (Unknown)

TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases

Total Raised: $66.00M

Last Funding: $41.00M (Series E)

Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.

Total Raised: $111.00M

Last Funding: $68.00M (Series D)

Protembis is a cerebral Protection System founded in 2013.

Total Raised: $64.67M

Last Funding: $21.67M (Debt Financing)

ITM Isotopen Technologien Munchen is a Munich-based developer of personalized cancer diagnostic solutions.

Total Raised: $205.00M

Last Funding: $205.00M (Series D)

Cytovale is a company that develops biomarkers based on the mechanical properties of cells to identify diseases. It has applied its technology to detect sepsis.

Total Raised: $119.30M

Last Funding: $100.00M (Series D)

Immune system-modulating technology platform for the treatment of cancer and autoimmune diseases.

Total Raised: $104.50M

Last Funding: $11.00M (Series C)

Oral antifungal therapy developer to treat life-threatening rare fungal infections

Total Raised: $170.00M

Last Funding: $100.00M (Series D)

ZAP Surgical Systems designs and manufactures the ZAP-X® radiosurgery platform.

Total Raised: $159.00M

Last Funding: $78.00M (Series E)

Gene therapies developer for pediatric patients.

Total Raised: $52.00M

Last Funding: $52.00M (Series B)

Small molecule MKK4 inhibitors to treat acute and chronic liver diseases

Total Raised: $37.60M

Last Funding: $16.00M (Series C)

Lumicks is a drug discovery platform for cancer founded in 2014 by Gerrit Sitters .

Total Raised: $114.90M

Last Funding: $21.90M (Debt Financing)

Inbrain Neuroelectronics is a developer of brain-computer interface therapeutics (BCI-Tx founded in 2020 by Carolina Aguilar.

Total Raised: $68.10M

Last Funding: $50.00M (Series B)

InterVene is an up and coming medical device start-up company reinventing the way physicians treat severe venous disease in the legs.

Total Raised: $28.00M

Last Funding: $13.00M (Series A)

Okami Medical develops and commercializes new devices for the treatment of heart disease.

Total Raised: $39.70M

Last Funding: $32.50M (Unknown)

Centaur Labs is a medical AI platform that offers medical data labeling services.

Total Raised: $16.15M

Last Funding: $16.00M (Series B)

Human genome sequencing company founded in 2013 and based in San Diego, CA. Human Longevity Inc. is building a database with genomic and phenotypic information and aims to make medicine more data-driven by combining DNA sequencing, expert analysis and machine learning

Total Raised: $39.80M

Last Funding: $39.80M (Series B)

TCR-based immunotherapies developer targeting novel dark antigens for cancer patients.

Total Raised: $32.50M

Last Funding: $32.50M (Series B)

Cerecin, formerly Accera, is a company that looks to develop therapeutic drugs for neurodegenerative diseases.

Total Raised: $59.50M

Last Funding: $11.00M (Series D)

Platform for scientists to gain new insights in spatial biology using Molecular Cartography.

Total Raised: $95.00M

Last Funding: $71.00M (Series B)

Shift Bioscience is an AI-driven cell simulation platform founded in 2017 by Daniel Ives.

Total Raised: $16.00M

Last Funding: $16.00M (Seed)

Holobiome is an owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems.

Total Raised: $9.00M

Last Funding: $9.00M (Seed)

AltraTech is a next-generation molecular detection technology developer founded in 2013 by Tim Cummins.

Total Raised: $11.50M

Last Funding: $11.50M (Series A)

SparingVision is a retinal Gene Therapy Treatments founded by Jose alain sahel.

Total Raised: $52.81M

Last Funding: $52.81M (Series A)

Immatics Biotechnologies is a biopharmaceutical company focused on the discovery and development of immunotherapy of cancer.

Total Raised: $180.09M

Last Funding: $58.00M (Series E)

Translate Bio is a clinical-stage mRNA therapeutics company developing medicines to treat diseases caused by protein or gene dysfunction and vaccines against infectious disease pathogens.

Total Raised: $183.00M

Last Funding: $47.50M (Unknown)

A healthcare technology company offering a cloud-based molecular profiling platform.

Total Raised: $250.80M

Last Funding: $250.80M (Series A)

Atonarp is a Tokyo-based electronics and data processing manufacturer developing spectrometers capable of gas-composition analysis.

Total Raised: $83.00M

Last Funding: $50.00M (Series D)

Invizius is a therapeutics developer for dialysis patients founded in 2018 by Andy Herbert.

Total Raised: $1.30M

Last Funding: $1.30M (Series A)

A company developing therapeutics for acute inflammatory central nervous system conditions

Total Raised: $24.30M

Last Funding: $6.50M (Series F)

Tubulis Therapeutics is a Munich-based therapeutics company developing matched protein-drug conjugates.

Total Raised: $75.30M

Last Funding: $63.00M (Series B)

Biopharmaceutical company developing protein therapeutics with a machine learning-driven evolution engine.

Total Raised: $83.17M

Last Funding: $3.70M (Seed)

Based in North Brunswick, New Jersey, Ascendia Pharmaceuticals is a specialty contract development and manufacturing (CDMO) company dedicated to delivering sophisticated formulations of existing drug products, and enabling formulations for preclinical- and clinical-stage drug candidates.

Total Raised: $2.50M

Last Funding: $2.50M (Unknown)

Provider of SITESEEKER platform for discovering new drugs.

Total Raised: $64.80M

Last Funding: $46.00M (Series B)

Small Molecules based on Omega-3 Fatty acid metabolites

Total Raised: $34.90M

Last Funding: $19.40M (Series C)

ITM Isotopen Technologien Munchen is a Munich-based developer of personalized cancer diagnostic solutions.

Total Raised: $36.20M

Last Funding: $36.20M (Unknown)

NantHealth is a Culver City, California-based company providing an evidence-based platform for healthcare diagnostics.

Total Raised: $100.00M

Last Funding: $75.00M (Unknown)

Adrenomed is a sepsis drug.

Total Raised: $26.30M

Last Funding: $26.30M (Series E)

ThinkCyte is a company focusing on image-activated cell sorting.

Total Raised: $26.00M

Last Funding: $26.00M (Series B)

Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.

Total Raised: $91.70M

Last Funding: $75.30M (Series B)

Immunocore Limited is a biotechnology research company based in Abingdon, Oxfordshire focused on developing therapies for the treatment of cancer.

Total Raised: $75.00M

Last Funding: $75.00M (Series C)

SOPHiA GENETICS is a healthcare technology company and developer of SOPHiA Artificial Intelligence for clinical genomics.

Total Raised: $110.00M

Last Funding: $110.00M (Unknown)

iOmx Therapeutics is a cancer Immunotherapy founded in 2016.

Total Raised: $75.26M

Last Funding: $75.26M (Series B)

Theseus Pharmaceuticals is a kinase Inhibitors founded by Wei-Sheng Huang.

Total Raised: $100.00M

Last Funding: $100.00M (Series B)

Abalos Therapeutics is a viral Immuno-Oncology Treatment founded in 2005.

Total Raised: $43.00M

Last Funding: $43.00M (Series A)

CENTOGENE is a Rostock-based healthcare company developing methods and technologies for genetics analysis.

Total Raised: $28.00M

Last Funding: $28.00M (Series A)

Platform using epigenetics to simplify routine diagnostic tests for common cancers to a simple blood draw.

Total Raised: $88.00M

Last Funding: $88.00M (Series D)

Healx is a biotechnology therapeutics company for rare diseases founded in 2014 by Tim Guilliams.

Total Raised: $56.00M

Last Funding: $56.00M (Series B)

Hifibio - High Fidelity Biology is a single cell technologies for drug discovery founded in 2013 by Liang Schweizer, Jeff He and Robert Nicol.

Total Raised: $75.00M

Last Funding: $75.00M (Series D)

Topas Therapeutics is a nanoparticles loaded with Antigenic Peptides.

Total Raised: $48.00M

Last Funding: $48.00M (Series B)

Hummingbird Diagnostics is an Heidelberg-based molecular diagnostics company developing liquid biopsy technology for early disease detection, personalized medicine, and lifetime monitoring of disease-specific biomarkers founded in 2017 by Ryan Gerard, Jesse Reiss, JoAnn Barefoot, Matthew Van Buskirk and Joe Robinson.

Total Raised: $8.20M

Last Funding: $8.20M (Series A)

GeneQuine Biotherapeutics GmbH is a German based biotechnology company that was founded in 2011

Total Raised: $9.88M

Last Funding: $3.37M (Unknown)

CND Life Sciences, Inc. is a synucleinopathy Diagnostic founded in 2017.

Total Raised: $7.50M

Last Funding: $2.50M (Unknown)

Lysogene is a company by Karen Aiach.

Total Raised: $16.50M

Last Funding: $16.50M (Series A)

Tacalyx is an antibodies for cancer founded in 2019.

Total Raised: $7.70M

Last Funding: $7.70M (Seed)

Research and development of innovative cancer treatments using protein nanoparticles for clinical phases.

Total Raised: $1.13M

Last Funding: $1.13M (Seed)

ActiTexx is a biotechnology company founded in 2020.

Total Raised: $4.20M

Last Funding: $4.20M (Series A)

Sample prep for proteins, peptides and proteomic analysis by MS

Total Raised: $3.80M

Last Funding: $3.80M (Series A)

Pantherna Therapeutics is a nanoparticle Delivery for mRNA drugs.

Total Raised: $3.90M

Last Funding: $3.90M (Seed)

Nostos Genomics is an AI-driven deciphering of genetic diseases founded in 2018 by David Gorgan.

Total Raised: $5.70M

Last Funding: $5.70M (Seed)

A software solutions company providing bioinformatics solutions to life science and other sector

Total Raised: $12.64M

Last Funding: $3.64M (Seed)

GNA Biosolutions is a Martinsried-based molecular diagnostics company.

Total Raised: $13.50M

Last Funding: $13.50M (Series C)

Carl Zeiss Meditec is a medical Devices founded in 2002 by Carl Zeiss.

Total Raised: $1.90M

Last Funding: $1.90M (Seed)

LenioBio is a cell-free protein expression kit founded in 2016.

Total Raised: $13.00M

Last Funding: $13.00M (Series A)

VisionGate is a Phoenix, Arizona-based in-vitro Automated 3D Cell Structure and Analysis founded in 2001 by Alan Nelson.

Total Raised: $2.00M

Last Funding: $2.00M (Unknown)

Mecuris is a 3D printed orthoses and prostheses founded in 2016.

Total Raised: $4.10M

Last Funding: $4.10M (Seed)

Caspr Biotech is developing a CRISPR-based platform for rapid diagnostic systems for viruses, bacteria and genetic mutations

Total Raised: $0.40M

Last Funding: $0.25M (Seed)